X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 31 filers reported holding X4 PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $417 | +145.3% | 382,134 | +334.8% | 0.00% | – |
| Q2 2023 | $170 | – | 87,879 | +87779.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 100 | -98.7% | 0.00% | – |
| Q1 2022 | $14,000 | -61.1% | 7,804 | -50.0% | 0.00% | – |
| Q4 2021 | $36,000 | -30.8% | 15,608 | +57.7% | 0.00% | – |
| Q3 2021 | $52,000 | -51.4% | 9,899 | -39.7% | 0.00% | – |
| Q2 2021 | $107,000 | -41.5% | 16,410 | -22.8% | 0.00% | – |
| Q1 2021 | $183,000 | +120.5% | 21,245 | +63.5% | 0.00% | – |
| Q4 2020 | $83,000 | +8200.0% | 12,993 | +9180.7% | 0.00% | – |
| Q2 2020 | $1,000 | -99.5% | 140 | -99.2% | 0.00% | – |
| Q4 2019 | $188,000 | +154.1% | 17,563 | +200.1% | 0.00% | – |
| Q3 2019 | $74,000 | +1750.0% | 5,852 | +2288.6% | 0.00% | – |
| Q1 2019 | $4,000 | – | 245 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 6,247,500 | $6,809,775 | 2.18% |
| Bain Capital Life Sciences Investors, LLC | 15,960,588 | $17,397,041 | 1.94% |
| Stonepine Capital Management, LLC | 5,273,685 | $5,748,317 | 1.91% |
| NEA Management Company, LLC | 14,986,793 | $16,335,604 | 1.26% |
| Sio Capital Management, LLC | 2,599,003 | $2,832,913 | 0.88% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $365,150 | 0.47% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,973,683 | $2,151,314 | 0.25% |
| Monashee Investment Management LLC | 427,265 | $465,719 | 0.20% |
| Orbimed Advisors | 7,133,515 | $7,775,531 | 0.16% |
| Parkman Healthcare Partners LLC | 800,000 | $872,000 | 0.16% |